Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease

Table 4 Correlation between fecal FC, MPO and EPX at inclusion, and after 4 and 8 wk of treatment in patients with UC and CD

Patients	Fecal marker	Inclusion	4 wk	8 wk
All	FC and MPO	R = 0.884, P < 0.01	R = 0.941, P < 0.01	R = 0.924, P < 0.01
All	FC and EPX	R = 0.592, P < 0.01	R = 0.724, P < 0.01	R = 0.642, P < 0.01
UC	FC and MPO	R = 0.868, P < 0.01	R = 0.927, P < 0.01	R = 0.940, P < 0.01
UC	FC and EPX	R = 0.556, P < 0.01	R = 0.762, P < 0.01	R = 0.602, P < 0.01
CD	FC and MPO	R = 0.936, P < 0.01	R = 0.818, P < 0.01	R = 0.903, P < 0.01
CD	FC and EPX	R = 0.654, P < 0.05	R = 0.636, P < 0.05	R = 0.854, P < 0.01

All: n = 38; UC: n = 27; CD: n = 11.